Navigation Links
WWMR Announces Pain Clinic Physicians' Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals
Date:11/20/2008

SAN FRANCISCO, Nov. 20 /PRNewswire/ -- WWMR, Inc., the marketing research leader in pain, announces results of the first annual "Most Appreciated Pain Drug Company Survey". The top three most appreciated companies are Pfizer, Eli Lilly and Endo Pharmaceuticals, according to the 100 pain clinic physicians surveyed in September 2008. These companies are most noted for their knowledgeable, respectful and informed sales representatives, their sampling/voucher plans, and their educational resources, as well as their drug products.

"While Pfizer, Lilly and Endo may be the most appreciated companies among many of the surveyed pain clinicians, there is plenty of opportunity for others to enhance their company image," stated Susan Olsen, President of WWMR, Inc. "A notable proportion of the pain clinicians surveyed noted that they don't appreciate any pain drug companies, and we view this is an opportunity waiting." Clients subscribing to the Pain Clinic Monitor have full access to this company image information, which outlines opportunities for companies to develop positive relationships with clinicians, and profiles competing companies.

Launched in January 2008, the Pain Clinic Monitor provides deep insights into the treatment of pain clinic-based chronic pain patients. The Pain Clinic Monitor provides a long-awaited perspective on the treatment of more than 10,000 patients with 27 different pain conditions. Information is available on in-office treatments as well as on up to seven pain drugs a patient has been prescribed, including why prescribed drugs have been tried, switched and discontinued.

The Pain Clinic Monitor is a monthly audit of a carefully balanced sample of 100 academic and nonacademic, office-based pain clinics, with each reporting treatment details for 10 patients. It is the basis for the 27 pain condition profiles provided as part of the Monitor. Companies, drug products and detai
'/>"/>

SOURCE WWMR, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Wound Management Technologies, Inc. Announces a Published Case Study
2. Histogen Announces Start of Hair Regrowth Clinical Evaluation
3. New Generation Biofuels Announces Test Burn Agreement With Progress Energy Florida
4. KGI Announces Second Annual Executive Education Conference for Women in Life Sciences
5. SyntheMed Announces FDA Clearance of SinusShield(TM)
6. Synvista Therapeutics Announces 510(k) Submission for Its HAPTOCHEK(TM) Test Kit
7. American HealthChoice Announces the First Sales of the OmniBody Scan
8. Tengion Announces Second Closing of Series C Financing
9. Penguin Computing Announces Niveus HTX Personal Supercomputer
10. Convey Computer™ Corporation Announces First Customer: University of California, San Diego at SC08 Conference
11. BBM Announces Offer to Acquire YM BioSciences Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...- SpineSmith Partners has signed an initial agreem...ffold that mimics the structure of natural cancell...ial products by SpineSmith,s Research and Developm...scaffold represents a significant advancement in t...ent for the delivery of adult stem cells for skele...
(Date:11/5/2009)...ialty firm BioSoteria announced that its Vice Pres...ified Professional in Learning and Performance&tra...r Training and Development (ASTD) Certification In...ears of medical communications and health care tra...pment of the company,s online pharmacovigilance cu...
(Date:11/5/2009)...rings a new look to Pro Repro , ...essional Reprographics, Orange County’s fast...esent Brooke Sanders to the company. Brooke joins ...ddition of Brooke to the company represents contin...ographics., , ,Brooke brings with her over five ye...
(Date:11/4/2009)...x Vaccine Program must be stopped. Scott Miller a...Call to Arms:2009 Edition" and the one-hour t...man Anthrax Vaccine Story" to inform the publ...t government science turned into for-profit human ...tims. It is available for world-wide licensing by...
Breaking Biology Technology:SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7
... -- WuXi PharmaTech,(Cayman) Inc. (NYSE: WX ), a ...device research and development outsourcing compan...today announced preliminary selected,unaudited fin...er 30, 2008,and updated its guidance for the full ...n/prnh/20040705/CNM002LOGO ), Third Quarter 2008...
...unique opportunities to advance the life sciences ...ervation of biological materials with unprecedente...ays of biological material assists studies of geno...lied to achieve increased sensitivity in drug scre...mes are severely limited. , Unfortunately, most ...
...ed today,that it has updated coverage on leading A..., (ASX: AAH; AIM: AAHx) and raised its target pric...s itself from many competitors,in the biotech spac...ring,revenue stream from IP licenses and a strong ...hnology platform. We strongly believe that Arana,s...
Other Biology Technology:WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 2WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 3WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 4WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 5WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 6WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 7WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 8Researchers write protein nanoarrays using a fountain pen and electric fields 2Researchers write protein nanoarrays using a fountain pen and electric fields 3Vista Partners Updates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx), Raises Target Price to AU$1.65 2
(Date:11/4/2009)...oma at Norman has received more than $10 million i...rt of the federal stimulus program, bringing theto...archers to $23 million. Thirty-three projects ach...chaeology to weather. , "The university has thou...ing areasof scholarly excellence to federal agency...
(Date:11/4/2009)...., Oct. 20 DigitalPersona, Inc., a... solutions, today announced that WAND Corporation,...e for quick-service restaurants, has integrated Di... Classic POS solutions. WAND,s quick-service custo...ashier accountability and deter unauthorized manag...
(Date:11/4/2009)...ct. 23 GenVault Corporation, the l...for genomic discovery, medicine and identification...lt,s President and CEO, will be presenting at the ... 26th and 27th in La Jolla, CA. ,, During the p...f the company together with recent customer, techn...
Breaking Biology News(10 mins):OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2SenesTech Announces New Vice President of Business Development 12862 1SenesTech Announces New Vice President of Business Development 12862 2Will IVF work for a particular patient 3F The answer may be found in her blood 9080 1Will IVF work for a particular patient 3F The answer may be found in her blood 9080 2Will IVF work for a particular patient 3F The answer may be found in her blood 9080 3This Summer EyeCare America and Celebrity Chefs Want You to Feast Your Eyes on Eye Healthy Foods 50489 1This Summer EyeCare America and Celebrity Chefs Want You to Feast Your Eyes on Eye Healthy Foods 50489 2This Summer EyeCare America and Celebrity Chefs Want You to Feast Your Eyes on Eye Healthy Foods 50489 3This Summer EyeCare America and Celebrity Chefs Want You to Feast Your Eyes on Eye Healthy Foods 50489 4This Summer EyeCare America and Celebrity Chefs Want You to Feast Your Eyes on Eye Healthy Foods 50489 5
...ogy developed at The University of Nottingham have...far. , Using a scientific technique known as Hydr...hey have been able to date chemical fossils discov...ion technique has shown that these fossil steroids...s, are between 635 and 750 million years old. They...
...ect interaction between vitamin D and a common gen...e sclerosis (MS). The research, published on 6 Feb...suggests that vitamin D deficiency during pregnanc... offspring developing MS later in life. , MS is t...fecting young adults. More than 85,000 people in t...
... availability of its complete suite of application...64x+(TM) high performance DSPs , , PLYMOUTH MEETI...aptive Digital), a leading provider of telecom and...SP) software solutions and voice quality enhancing...ts complete suite of application-specific VoIP chi...
Other Biology News:Engineering technology pinpoints earliest signs of animal life 2Genetic study shows direct link between vitamin D and MS susceptibility 'gene' 2Genetic study shows direct link between vitamin D and MS susceptibility 'gene' 3High Performance, Low-Cost VoIP Chips Address Critical Performance Issues Such as Echo, Latency, and Packet Loss 2High Performance, Low-Cost VoIP Chips Address Critical Performance Issues Such as Echo, Latency, and Packet Loss 3
Techne hybridization oven HB-1D from Sigma-Aldrich
...s solution that contains a purified bovine protein...S buffer (4-Morpholine-ethanesulfonic acid), pH 5....02% methylisothiazolone and 0.02% bromonitrodioxan...ilizer is formulated specifically for Alkaline Pho...
Mouse Anti-Lambda Free Light Chain Monoclonal Antibody, Unconjugated, Clone 3D12 from GeneTex
BlueView Nucleic Acid Stain from Sigma-Aldrich
Biology Products: